Hi all,
I am new on RNE and doing some homework...
Does anyone know what the annualised EBITDA rate is at with the new Bio Energy projects and solar projects?
Chairman said they are targeting EBITDA of $2M by 30 June 2018. Are they close?
Based on this EV at 30 March is $8.5M
assuming forecast cashflow for 30th June is correct then EV is at $6.5M
If they achieve $2M EBITDA run rate - RNE is trading on EV/EBITDA of 3.3x.
With all the tax losses they have, its mainly amortisation and depreciation that hits the bottomline.
Key is hitting they $2M annualised run rate conservatively I think. Can anyone help shed some light (pun intended)
- Forums
- ASX - By Stock
- RNE
- Ann: Head of Terms to fund $100m bioenergy business development
Ann: Head of Terms to fund $100m bioenergy business development, page-41
Featured News
Add RNE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.727M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $2.603K | 2.603M |
Featured News
RNE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online